Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients. (Q54501555)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 December 2013

Language	Label	Description	Also known as
English	Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.	scientific article published on 3 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

0 references

diffusion-weighted magnetic resonance imaging

1 reference

based on heuristic

inferred from title

computed tomography

1 reference

based on heuristic

inferred from title

object named as

Tobias Maurer

6

0 references

Markus Schwaiger

object named as

Markus Schwaiger

12

0 references

Ernst J. Rummeny

11

object named as

Ernst J Rummeny

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

author name string

Matthias M Heck

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Michael Souvatzoglou

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Margitta Retz

3

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Roman Nawroth

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Hubert Kübler

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Mark Thalgott

7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Bettina M Gramer

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Gregor Weirich

9

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Ina-Christine Rondak

10

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Jürgen E Gschwend

13

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Bernd Krause

14

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Matthias Eiber

15

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

publication date

3 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

41

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

694-701

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Nonparametric analysis of clustered ROC curve data

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Visualization of prostate cancer with 11C-choline positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2634-1

21 January 2018

Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatecto

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is a limited lymph node dissection an adequate staging procedure for prostate cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of prostate carcinoma death in patients with lymph node metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297503

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-013-2634-1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/24297503

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54501555&oldid=2212490194"